Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,297 public trials 434 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Recruiting

Screen2Prevent (S2P)

NCT07728123

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
Locations
  • University of South Florida Tampa, Florida, United States
  • Emory Atlanta Adolescent Consortium Atlanta, Georgia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
View Trial Details
Recruiting

A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment

NCT07393659

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Durban, KwaZulu-Natal, South Africa
  • GSK Investigational Site Jouberton, Matlosana, South Africa
  • GSK Investigational Site Gauteng, South Africa
  • GSK Investigational Site Johannesburg, South Africa
View Trial Details
Recruiting

Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

NCT07040319

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • USC LA Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Univ. of Florida Jacksonville Jacksonville, Florida, United States
View Trial Details
Recruiting

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

NCT07650916

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 88 locations
View Trial Details
Recruiting

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

NCT07682961

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • CAN Community Health Fort Lauderdale Fort Lauderdale, Florida, United States
  • Midway Immunology and Research Center Ft. Pierce, Florida, United States
  • Be Well Medical Center Berkley, Michigan, United States
  • Optimus Medical Group San Francisco, California, United States
View all 19 locations
View Trial Details
Recruiting

National Liver Cancer Screening Trial

NCT06084234

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +22 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Stanford University Redwood City, California, United States
  • Kaiser Permanente Roseville, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 19 locations
View Trial Details

Related conditions